← Back to Search

Anti-inflammatory agent

AMT-101 for Ulcerative Colitis

Phase 2
Waitlist Available
Research Sponsored by Applied Molecular Transport
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This study is evaluating whether a drug called AMT-101 may help treat ulcerative colitis.

Eligible Conditions
  • Ulcerative Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mayo Score
Secondary outcome measures
Clinical Remission Rate
Endoscopic Remission Rate
Histologic Remission Rate
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: AMT-101Active Control1 Intervention
AMT-101 Tablet
Group II: PlaceboPlacebo Group1 Intervention
Placebo Tablet

Find a Location

Who is running the clinical trial?

Applied Molecular TransportLead Sponsor
4 Previous Clinical Trials
175 Total Patients Enrolled
2 Trials studying Ulcerative Colitis
103 Patients Enrolled for Ulcerative Colitis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for participants to join this scientific investigation?

"According to clinicaltrials.gov, this medicinal investigation is no longer recruiting patients, having been posted on August 26th 2020 and last updated November 3rd 2022. Fortunately, there are 406 other studies actively seeking volunteers at present."

Answered by AI

Is there an age limit for individuals seeking to participate in this trial?

"The age range for participation in this medical trial is between 18 and 80. On the other hand, there are 70 trials designed specifically for minors under 18 years old and 345 clinical studies open to those who exceed 65 years of age."

Answered by AI

Who is eligible to enroll in this trial?

"This medical trial is recruiting 105 individuals with colitis, ulcerative aged between 18 and 80. To be eligible for the study, applicants must meet these prerequisites: of both genders between ages 18 to 75 years old, female participants able to prove their non-pregnancy status prior to randomization visit and participation in all aspects of this clinical research project."

Answered by AI

How many establishments are hosting this trial?

"This research initiative is being conducted across a variety of medical centres, including Vanderbilt University Medical Center in Nashville, Utah, University of Utah Hospitals and Clinics in Salt Lake City, Washington, and Gastro One in Germantown. Furthermore there are 20 other sites participating globally."

Answered by AI

To what extent is AMT-101 deemed a safe treatment option?

"Our team at Power assessed AMT-101's safety to be a 2 on the scale of 1 to 3 as it is only in Phase 2, thus there is information confirming its security but no efficacy data yet."

Answered by AI
~23 spots leftby Apr 2025